HIGHLIGHTS
- who: September et al. from the University of Perugia, Italy have published the paper: Ef cacy and safety of neoadjuvant imatinib therapy for patients with locally advanced rectal gastrointestinal stromal tumors: A multi-center cohort study, in the Journal: (JOURNAL)
- what: Current study, the authors aimed to describe the clinicopathological characteristics and prognosis of locally advanced rectal GIST patients receiving surgical treatment in the center with or without neoadjuvant imatinib therapy, and compare the surgical and oncologic outcomes between these two populations.
SUMMARY
Rectal GIST is a rare entity, accounting for . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.